RULID

This brand name is authorized in Cyprus, Germany, France, Japan, Poland, Tunisia, Turkey

Active ingredients

The drug RULID contains one active pharmaceutical ingredient (API):

1 Roxithromycin UNII 21KOF230FA - ROXITHROMYCIN

Roxithromycin is a semi-synthetic macrolide antibiotic. Roxithromycin is bacteriostatic at low concentrations and bactericidal at high concentrations. It binds to the 50S subunit of the 70S ribosome, thereby disrupting bacterial protein synthesis. Read about Roxithromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA06	Roxithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 03755578, 04462016, 04644616
Country: FR	Base de données publique des médicaments	Identifier(s): 65393957, 68658161
Country: JP	医薬品医療機器総合機構	Identifier(s): 6149002F1029
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100000391, 100059065
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9263181
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809096608, 8699809096615